How can the findings of the EMAX trial on long-acting bronchodilation in chronic obstructive pulmonary disease be applied in the primary care setting?
Chron Respir Dis. 2023 Jan-Dec;20:14799731231202257. doi: 10.1177/14799731231202257.ABSTRACTThis review addresses outstanding questions regarding initial pharmacological management of chronic obstructive pulmonary disease (COPD). Optimizing initial treatment improves clinical outcomes in symptomatic patients, including those with low exacerbation risk. Long-acting muscarinic antagonist/long-acting β2-agonist (LAMA/LABA) dual therapy improves lung function versus LAMA or LABA monotherapy, although other treatment benefits have been less consistently observed. The benefits of dual bronchodilation in symptomatic patients wit...
Source: Chronic Respiratory Disease - October 6, 2023 Category: Respiratory Medicine Authors: Edward M Kerwin Paul W Jones Leif H Bjermer Fran çois Maltais Isabelle H Boucot Ian P Naya David A Lipson Chris Compton Lee Tombs Claus F Vogelmeier Source Type: research
How can the findings of the EMAX trial on long-acting bronchodilation in chronic obstructive pulmonary disease be applied in the primary care setting?
Chron Respir Dis. 2023 Jan-Dec;20:14799731231202257. doi: 10.1177/14799731231202257.ABSTRACTThis review addresses outstanding questions regarding initial pharmacological management of chronic obstructive pulmonary disease (COPD). Optimizing initial treatment improves clinical outcomes in symptomatic patients, including those with low exacerbation risk. Long-acting muscarinic antagonist/long-acting β2-agonist (LAMA/LABA) dual therapy improves lung function versus LAMA or LABA monotherapy, although other treatment benefits have been less consistently observed. The benefits of dual bronchodilation in symptomatic patients wit...
Source: Chronic Respiratory Disease - October 6, 2023 Category: Respiratory Medicine Authors: Edward M Kerwin Paul W Jones Leif H Bjermer Fran çois Maltais Isabelle H Boucot Ian P Naya David A Lipson Chris Compton Lee Tombs Claus F Vogelmeier Source Type: research
How can the findings of the EMAX trial on long-acting bronchodilation in chronic obstructive pulmonary disease be applied in the primary care setting?
Chron Respir Dis. 2023 Jan-Dec;20:14799731231202257. doi: 10.1177/14799731231202257.ABSTRACTThis review addresses outstanding questions regarding initial pharmacological management of chronic obstructive pulmonary disease (COPD). Optimizing initial treatment improves clinical outcomes in symptomatic patients, including those with low exacerbation risk. Long-acting muscarinic antagonist/long-acting β2-agonist (LAMA/LABA) dual therapy improves lung function versus LAMA or LABA monotherapy, although other treatment benefits have been less consistently observed. The benefits of dual bronchodilation in symptomatic patients wit...
Source: Chronic Respiratory Disease - October 6, 2023 Category: Respiratory Medicine Authors: Edward M Kerwin Paul W Jones Leif H Bjermer Fran çois Maltais Isabelle H Boucot Ian P Naya David A Lipson Chris Compton Lee Tombs Claus F Vogelmeier Source Type: research
How can the findings of the EMAX trial on long-acting bronchodilation in chronic obstructive pulmonary disease be applied in the primary care setting?
Chron Respir Dis. 2023 Jan-Dec;20:14799731231202257. doi: 10.1177/14799731231202257.ABSTRACTThis review addresses outstanding questions regarding initial pharmacological management of chronic obstructive pulmonary disease (COPD). Optimizing initial treatment improves clinical outcomes in symptomatic patients, including those with low exacerbation risk. Long-acting muscarinic antagonist/long-acting β2-agonist (LAMA/LABA) dual therapy improves lung function versus LAMA or LABA monotherapy, although other treatment benefits have been less consistently observed. The benefits of dual bronchodilation in symptomatic patients wit...
Source: Chronic Respiratory Disease - October 6, 2023 Category: Respiratory Medicine Authors: Edward M Kerwin Paul W Jones Leif H Bjermer Fran çois Maltais Isabelle H Boucot Ian P Naya David A Lipson Chris Compton Lee Tombs Claus F Vogelmeier Source Type: research
Prevalence and assessment of frailty in interstitial lung disease - a systematic review and meta-analysis
CONCLUSIONS: Frailty is common in ILD, with considerable variability of frailty prevalence depending on the frailty assessment tool used. These findings highlight the importance of frailty in ILD and the need for a standardized approach to frailty assessment in this population.PMID:37746859 | PMC:PMC10521296 | DOI:10.1177/14799731231196582 (Source: Chronic Respiratory Disease)
Source: Chronic Respiratory Disease - September 25, 2023 Category: Respiratory Medicine Authors: Angela Weber Ilena M üller Annina E B üchi Sabina A Guler Source Type: research
Prevalence and assessment of frailty in interstitial lung disease - a systematic review and meta-analysis
CONCLUSIONS: Frailty is common in ILD, with considerable variability of frailty prevalence depending on the frailty assessment tool used. These findings highlight the importance of frailty in ILD and the need for a standardized approach to frailty assessment in this population.PMID:37746859 | PMC:PMC10521296 | DOI:10.1177/14799731231196582 (Source: Chronic Respiratory Disease)
Source: Chronic Respiratory Disease - September 25, 2023 Category: Respiratory Medicine Authors: Angela Weber Ilena M üller Annina E B üchi Sabina A Guler Source Type: research
Prevalence and assessment of frailty in interstitial lung disease - a systematic review and meta-analysis
CONCLUSIONS: Frailty is common in ILD, with considerable variability of frailty prevalence depending on the frailty assessment tool used. These findings highlight the importance of frailty in ILD and the need for a standardized approach to frailty assessment in this population.PMID:37746859 | PMC:PMC10521296 | DOI:10.1177/14799731231196582 (Source: Chronic Respiratory Disease)
Source: Chronic Respiratory Disease - September 25, 2023 Category: Respiratory Medicine Authors: Angela Weber Ilena M üller Annina E B üchi Sabina A Guler Source Type: research
Prevalence and assessment of frailty in interstitial lung disease - a systematic review and meta-analysis
CONCLUSIONS: Frailty is common in ILD, with considerable variability of frailty prevalence depending on the frailty assessment tool used. These findings highlight the importance of frailty in ILD and the need for a standardized approach to frailty assessment in this population.PMID:37746859 | PMC:PMC10521296 | DOI:10.1177/14799731231196582 (Source: Chronic Respiratory Disease)
Source: Chronic Respiratory Disease - September 25, 2023 Category: Respiratory Medicine Authors: Angela Weber Ilena M üller Annina E B üchi Sabina A Guler Source Type: research
Prevalence and assessment of frailty in interstitial lung disease - a systematic review and meta-analysis
CONCLUSIONS: Frailty is common in ILD, with considerable variability of frailty prevalence depending on the frailty assessment tool used. These findings highlight the importance of frailty in ILD and the need for a standardized approach to frailty assessment in this population.PMID:37746859 | PMC:PMC10521296 | DOI:10.1177/14799731231196582 (Source: Chronic Respiratory Disease)
Source: Chronic Respiratory Disease - September 25, 2023 Category: Respiratory Medicine Authors: Angela Weber Ilena M üller Annina E B üchi Sabina A Guler Source Type: research
Prevalence and assessment of frailty in interstitial lung disease - a systematic review and meta-analysis
CONCLUSIONS: Frailty is common in ILD, with considerable variability of frailty prevalence depending on the frailty assessment tool used. These findings highlight the importance of frailty in ILD and the need for a standardized approach to frailty assessment in this population.PMID:37746859 | PMC:PMC10521296 | DOI:10.1177/14799731231196582 (Source: Chronic Respiratory Disease)
Source: Chronic Respiratory Disease - September 25, 2023 Category: Respiratory Medicine Authors: Angela Weber Ilena M üller Annina E B üchi Sabina A Guler Source Type: research
Prevalence and assessment of frailty in interstitial lung disease - a systematic review and meta-analysis
CONCLUSIONS: Frailty is common in ILD, with considerable variability of frailty prevalence depending on the frailty assessment tool used. These findings highlight the importance of frailty in ILD and the need for a standardized approach to frailty assessment in this population.PMID:37746859 | PMC:PMC10521296 | DOI:10.1177/14799731231196582 (Source: Chronic Respiratory Disease)
Source: Chronic Respiratory Disease - September 25, 2023 Category: Respiratory Medicine Authors: Angela Weber Ilena M üller Annina E B üchi Sabina A Guler Source Type: research
Prevalence and assessment of frailty in interstitial lung disease - a systematic review and meta-analysis
CONCLUSIONS: Frailty is common in ILD, with considerable variability of frailty prevalence depending on the frailty assessment tool used. These findings highlight the importance of frailty in ILD and the need for a standardized approach to frailty assessment in this population.PMID:37746859 | PMC:PMC10521296 | DOI:10.1177/14799731231196582 (Source: Chronic Respiratory Disease)
Source: Chronic Respiratory Disease - September 25, 2023 Category: Respiratory Medicine Authors: Angela Weber Ilena M üller Annina E B üchi Sabina A Guler Source Type: research
Prevalence and assessment of frailty in interstitial lung disease - a systematic review and meta-analysis
CONCLUSIONS: Frailty is common in ILD, with considerable variability of frailty prevalence depending on the frailty assessment tool used. These findings highlight the importance of frailty in ILD and the need for a standardized approach to frailty assessment in this population.PMID:37746859 | DOI:10.1177/14799731231196582 (Source: Chronic Respiratory Disease)
Source: Chronic Respiratory Disease - September 25, 2023 Category: Respiratory Medicine Authors: Angela Weber Ilena M üller Annina E B üchi Sabina A Guler Source Type: research
Effect of a pulmonary rehabilitation program combined with cognitive training on exercise tolerance and cognitive functions among Tunisian male patients with chronic obstructive pulmonary disease: A randomized controlled trial
CONCLUSION: In conclusion, although PR alone improves 6MWT parameters and cognitive function, the addition of CT to PR is more effective in improving cognitive abilities in patients with COPD. This combined approach may provide clinicians with a complementary therapeutic option for improving cognitive abilities in patients with COPD.PMID:37691169 | PMC:PMC10494516 | DOI:10.1177/14799731231201643 (Source: Chronic Respiratory Disease)
Source: Chronic Respiratory Disease - September 11, 2023 Category: Respiratory Medicine Authors: Oussama Tabka Imen Sanaa Marwa Mekki Amal Acheche Thierry Paillard Yassine Trabelsi Source Type: research
Effect of a pulmonary rehabilitation program combined with cognitive training on exercise tolerance and cognitive functions among Tunisian male patients with chronic obstructive pulmonary disease: A randomized controlled trial
CONCLUSION: In conclusion, although PR alone improves 6MWT parameters and cognitive function, the addition of CT to PR is more effective in improving cognitive abilities in patients with COPD. This combined approach may provide clinicians with a complementary therapeutic option for improving cognitive abilities in patients with COPD.PMID:37691169 | PMC:PMC10494516 | DOI:10.1177/14799731231201643 (Source: Chronic Respiratory Disease)
Source: Chronic Respiratory Disease - September 11, 2023 Category: Respiratory Medicine Authors: Oussama Tabka Imen Sanaa Marwa Mekki Amal Acheche Thierry Paillard Yassine Trabelsi Source Type: research
